Movano Health Prices $6.5 Million Public Offering
Movano Health (Nasdaq: MOVE) has priced a $6.5 million underwritten public offering involving 4,644,000 shares of common stock and warrants for 2,322,000 shares. Each share and warrant is priced at $1.40 and $1.57 respectively, with the offering expected to close on January 31, 2023. The company plans to use the proceeds for general corporate purposes, including product development and commercialization. Newbridge Securities Corporation is the sole book-running manager for this offering, which may have a 30-day option for the underwriter to purchase an additional 15% of the offering.
- Proceeds from the offering will support product development and commercialization activities.
- The pricing of the offering is structured to attract investor interest with a clear exercise price for the warrants.
- The offering may lead to shareholder dilution due to the issuance of additional shares.
- Market conditions may affect the successful completion of the offering.
The Company intends to use the net proceeds from the offering for general corporate purposes, which may include funding product development and commercialization activities.
The common stock and warrants to purchase common stock described above were offered by Movano pursuant to a registration statement previously filed with and subsequently declared effective by the
About
Founded in 2018,
Movano Health's
Forward Looking Statements
This press release contains forward-looking statements regarding the expected closing of the public offering and the intended use of proceeds from the offering. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially, including those risks disclosed in the section "Risk Factors" included in the preliminary prospectus supplement for the offering. Movano cautions readers not to place undue reliance on any forward-looking statements. Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-health-prices-6-5-million-public-offering-301732376.html
SOURCE Movano
FAQ
What is the size of Movano Health's recent public offering?
When is the expected closing date for the Movano Health offering?
What will Movano Health do with the proceeds from its public offering?
What are the details of the warrants issued in the Movano Health offering?